Kaiser Permanente Ventures and Cigna Ventures participated in a $34 million funding round for NOCD, a company that offers virtual treatment for obsessive-compulsive disorder.
Read the full post on Becker's Hospital Review - Healthcare News
Kaiser Permanente Ventures and Cigna Ventures participated in a $34 million funding round for NOCD, a company that offers virtual treatment for obsessive-compulsive disorder.
Read the full post on Becker's Hospital Review - Healthcare News